文档介绍：Copyright © prehensive work 2011. All rights reserved. “”, the logo, and “prehensive work” are
registered trademarks of the prehensive work.
The Chinese edition of Clinical Practice Guidelines in Oncology-Kidney Cancer Guideline 2011 is the Chinese adapted version of Clinical Practice
Guidelines in Oncology-Kidney Cancer Guideline, as permitted and endorsed by . It is the collaborative e of the prehensive Cancer
Network and Chinese key opinion leaders of the field.
The original guideline and Chinese edition are both available at: . To view the most recent plete version of the guideline, go online to
. These Guidelines and illustrations herein may not be reproduced in any form for any purpose without the express written permission of the .
These Guidelines are a work in progress that will be refined as often as new significant data es available. The Guidelines are a statement of consensus
of its authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult any guideline is expected to use
independent medical judgment in the context of individual clinical circumstance to determine any patient's care or treatment. The prehensive Cancer
Network makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
This publication should not be used mercial purpose. It is provided for free to Chinese medical professions with the support of the unrestrictive educational
grant of Bayer Healthcare Co. Ltd. which exerts no influence to the formation of the Chinese edition of Clinical Practice Guidelines in Oncology-Kidney Cancer
Guideline 2011.
肾癌
肾癌专家组成员
*Robert J. Motzer, MD/Chair †Þ Eric Jonasch, MD † Cary N. Robertson, MD ω
Memorial Sloan-Kettering Cancer Center The University of Texas M. D. Anderson prehensive Cancer Center
Cancer Center
Neeraj Agarwal, MD ‡ Charles J.